miRNA155在人类恶性肿瘤中的研究进展
Research Progress of miRNA155 in Human Malignant Tumors
DOI: 10.12677/ACM.2023.133627, PDF,   
作者: 韩 青：济宁医学院临床医学院，山东 济宁；张 健*：济宁市第一人民医院消化内科，山东 济宁
关键词: 恶性肿瘤；miRNA155；基因调控；Malignant Tumor； miRNA155； Gene Regulation
摘要: 恶性肿瘤严重威胁人类生命健康，微小RNA (micro RNA, miRNA)在恶性肿瘤的发生进展中起重要作用，表达失调的miRNAs可通过调控相关靶基因，进而参与肿瘤细胞的增殖与凋亡、转移与侵袭以及耐药性等生物学过程。本文系统性地从肿瘤的发生发展、转移、治疗及预后等方面探讨了miRNA155在各种恶性肿瘤中的重要作用，为后续进一步的实验及临床研究提供参考。
Abstract: Malignant tumors are a serious threat to human life and health. Micrornas (miRNAs) play an im-portant role in the occurrence and progression of malignant tumors. Dysregulated miRNAs can par-ticipate in the proliferation, apoptosis, metastasis, invasion, drug resistance and other biological processes of tumor cells by regulating related target genes. This article systematically discusses the important role of miRNA155 in the occurrence, development, metastasis, treatment and prognosis of various malignant tumors, and provides reference for further experimental and clinical studies.
文章引用：韩青, 张健. miRNA155在人类恶性肿瘤中的研究进展[J]. 临床医学进展, 2023, 13(3): 4374-4381. https://doi.org/10.12677/ACM.2023.133627

参考文献

[1] 王明阳, 王光磊, 陈新亮, 张燚, 龙淼. MicroRNA的生物学功能及其与肿瘤诊断和治疗的研究进展[J]. 动物医学进展, 2018, 39(1): 95-98.
[2] Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. Elegans Heterochronic Gene lin-4 Encodes Small RNAs with Antisense Complementarity to lin-14. Cell, 75, 843-854. [Google Scholar] [CrossRef] 
[3] Khan, S., Ayub, H., Khan, T. and Wahid, F. (2019) Mi-croRNA Biogenesis, Gene Silencing Mechanisms and Role in Breast, Ovarian and Prostate Cancer. Biochimie, 167, 12-24. [Google Scholar] [CrossRef] [PubMed]
[4] Pattarayan, D., Thimmulappa, R.K., Ravikumar, V. and Rajasekaran, S. (2018) Diagnostic Potential of Extracellular MicroRNA in Respiratory Diseases. Clinical Reviews in Al-lergy & Immunology, 54, 480-492. [Google Scholar] [CrossRef] [PubMed]
[5] 李欣, 罗小玲. miRNA调控肿瘤微环境的研究进展[J]. 现代免疫学, 2019, 39(3): 245-248.
[6] Krol, J., Loedige, I. and Filipowicz, W. (2010) The Widespread Regulation of mi-croRNA Biogenesis, Function and Decay. Nature Reviews Genetics, 11, 597-610. [Google Scholar] [CrossRef] [PubMed]
[7] 马威, 陈爱娣, 古日珍, 朱利容, 郭君. 不同检查联合在乳腺癌中的诊断价值分析[J]. 影像研究与医学应用, 2020, 4(21): 203-204.
[8] Liu, X., Li, Y., Li, Z. and Hou, T. (2021) MiR-155 Promotes Proliferation and Epithelial-Mesenchymal Transition of MCF-7 Cells. Experimental and Therapeutic Medicine, 21, Article No. 218. [Google Scholar] [CrossRef] [PubMed]
[9] Fan, T., Mao, Y., Sun, Q., Liu, F., Lin, J.-S., Liu, Y., Cui, J. and Jiang, Y. (2018) Branched Rolling Circle Amplification Method for Measuring Serum Circulating mi-croRNA Levels for Early Breast Cancer Detection. Cancer Science, 109, 2897-2906. [Google Scholar] [CrossRef] [PubMed]
[10] Song, X., Liu, Z. and Yu, Z. (2019) LncRNA NEF Is Downregulated in Triple Negative Breast Cancer and Correlated with Poor Prognosis. Acta Biochimica et Biophysica Sinica, 51, 386-392. [Google Scholar] [CrossRef] [PubMed]
[11] Zhang, W., Chen, C.-J. and Guo, G.-L. (2018) MiR-155 Promotes the Proliferation and Migration of Breast Cancer Cells via Targeting SOCS1 and MMP16. European Review for Medical and Pharmacological Sciences, 22, 7323-7332.
[12] 周琦, 吴小华, 刘继红, 等. 宫颈癌诊断与治疗指南(第四版) [J]. 中国实用妇科与产科杂志, 2018, 34(6): 613-622.
[13] Lei, C., Wang, Y., Huang, Y., Yu, H., Huang, Y., Wu, L. and Huang, L. (2012) Up-Regulated miR155 Reverses the Epithelial-Mesenchymal Transition Induced by EGF and Increases Chemo-Sensitivity to Cisplatin in Human Caski Cervical Cancer Cells. PLOS ONE, 7, e52310. [Google Scholar] [CrossRef] [PubMed]
[14] Qureshi, R., Arora, H. and Rizvi, M.A. (2015) EMT in Cervical Cancer: Its Role in Tumour Progression and Response to Therapy. Cancer Letters, 356, 321-331. [Google Scholar] [CrossRef] [PubMed]
[15] Lao, G., Liu, P., Wu, Q., Zhang, W., Liu, Y., Yang, L. and Ma, C. (2014) Mir-155 Promotes Cervical Cancer Cell Proliferation through Suppression of Its Target Gene LKB1. Tumor Bi-ology, 35, 11933-11938. [Google Scholar] [CrossRef] [PubMed]
[16] Fang, H., Shuang, D., Yi, Z., Sheng, H. and Liu, Y. (2016) Up-Regulated microRNA-155 Expression Is Associated with Poor Prognosis in Cervical Cancer Patients. Biomedicine & Pharmacotherapy, 83, 64-69. [Google Scholar] [CrossRef] [PubMed]
[17] Chen, Y.-Z., Wang, J.-W., Meng, F.-C., Yang, P., Zhang, X.-G. and Wu, H.-Z. (2019) LncRNATCF7 up-Regulates DNMT1 Mediated by HPV-18 E6 and Regulates Biological Behav-ior of Cervical Cancer Cells by Inhibiting miR-155. European Review for Medical and Pharmacological Sciences, 23, 8779-8787.
[18] Jia, J., Li, X., Guo, S. and Xie, X. (2020) MicroRNA-155 Suppresses the Translation of p38 and Im-pairs the Functioning of Dendritic Cells in Endometrial Cancer Mice. Cancer Management and Research, 12, 2993-3002. [Google Scholar] [CrossRef] 
[19] Hermyt, E., Zmarzły, N., Grabarek, B., Kruszniewska-Rajs, C., Gola, J., Jęda-Golonka, A., Szczepanek, K., Mazurek, U. and Witek, A. (2019) Interplay between miRNAs and Genes Associ-ated with Cell Proliferation in Endometrial Cancer. International Journal of Molecular Sciences, 20, Article No. 6011. [Google Scholar] [CrossRef] [PubMed]
[20] 刘宗超, 李哲轩, 张阳, 等. 2020全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 1-13.
[21] Shao, C., Yang, F., Qin, Z., Jing, X., Shu, Y. and Shen, H. (2019) The Value of miR-155 as a Biomarker for the Diagnosis and Prognosis of Lung Cancer: A Systematic Review with Me-ta-Analysis. BMC Cancer, 19, Article No. 1103. [Google Scholar] [CrossRef] [PubMed]
[22] Zhu, H.-Z., Hou, J., Guo, Y., Liu, X., Jiang, F.-L., Chen, G.-P., Pang, X.-F., Sun, J.-G. and Chen, Z.-T. (2018) Identification and Imaging of miR-155 in the Early Screening of Lung Cancer by Targeted Delivery of Octreotide-Conjugated Chitosan-Molecular Beacon Nanoparticles. Drug Delivery, 25, 1974-1983. [Google Scholar] [CrossRef] [PubMed]
[23] Zang, Y.-S., Zhong, Y.-F., Fang, Z., Li, B. and An, J. (2012) MiR-155 Inhibits the Sensitivity of Lung Cancer Cells to Cisplatin via Negative Regulation of Apaf-1 Expression. Can-cer Gene Therapy, 19, 773-778. [Google Scholar] [CrossRef] [PubMed]
[24] 吕炎, 王艳华, 苏利佳, 苏华华. miRNA-122在肿瘤发生发展中的研究进展[J]. 癌症进展, 2021, 19(18): 1847-1851.
[25] Li, C.-L., Nie, H., Wang, M., Su, L.-P., Li, J.-F., Yu, Y.-Y., Yan, M., Qu, Q.-L., Zhu, Z.-G. and Liu, B.-Y. (2012) MicroRNA-155 Is Downregulated in Gastric Cancer Cells and Involved in Cell Metastasis. Oncology Reports, 27, 1960-1966.
[26] Ma, Z., Ma, Y., Xia, Q., Li, Y., Li, R., Chang, W., Chen, J., Leng, Z. and Tao, K. (2016) MicroRNA-155 Expression Inversely Correlates with Pathologic Stage of Gastric Cancer and It Inhibits Gastric Cancer Cell Growth by Targeting Cyclin D1. Journal of Cancer Research and Clinical Oncology, 142, 1201-1212. [Google Scholar] [CrossRef] [PubMed]
[27] 张南翔. miRNA-155在胃癌中的表达及意义[D]: [硕士学位论文]. 长沙: 中南大学, 2014.
[28] 曹兵, 季涛, 周斌, 等. miRNA-155在胃癌组织中的表达及意义[J]. 实用临床医药杂志, 2013, 17(21): 43-45.
[29] Li, Y., Tian, Z., Tan, Y., Lian, G., Chen, S., Chen, S., Li, J., Li, X., Huang, K. and Chen, Y. (2020) Bmi-1-Induced miR-27a and miR-155 Promote Tumor Metastasis and Chemoresistance by Target-ing RKIP in Gastric Cancer. Molecular Cancer, 19, Article No. 109. [Google Scholar] [CrossRef] [PubMed]
[30] Qu, Y., Zhang, H., Sun, W., Han, Y., Li, S., Qu, Y., Ying, G. and Ba, Y. (2018) MicroRNA-155 Promotes Gastric Cancer Growth and Invasion by Negatively Regulating Transform-ing Growth Factor-β Receptor 2. Cancer Science, 109, 618-628. [Google Scholar] [CrossRef] [PubMed]
[31] Yin, L., Liu, T., Li, C., Yan, G., Li, C., Zhang, J. and Wang, L. (2020) The MRTF-A/miR-155/SOX1 Pathway Mediates Gastric Cancer Migration and Invasion. Cancer Cell International, 20, Article No. 303. [Google Scholar] [CrossRef] [PubMed]
[32] Baidoun, F., Elshiwy, K., Elkeraie, Y., Merjaneh, Z., Khoudari, G., Sarmini, M.T., Gad, M., Al-Husseini, M. and Saad, A. (2021) Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes. Current Drug Targets, 22, 998-1009. [Google Scholar] [CrossRef] [PubMed]
[33] Nassar, F.J., Msheik, Z.S., Itani, M.M., Helou, R.E., Hadla, R., Kreidieh, F., Bejjany, R., Mukherji, D., Shamseddine, A., Nasr, R.R. and Temraz, S.N. (2021) Circulating miRNA as Biomarkers for Colorectal Cancer Diagnosis and Liver Metastasis. Diagnostics, 11, Article No. 341. [Google Scholar] [CrossRef] [PubMed]
[34] Zhang, X.-F., Tu, R., Li, K., Ye, P. and Cui, X. (2017) Tumor Suppressor PTPRJ Is a Target of miR-155 in Colorectal Cancer. Journal of Cellular Biochemistry, 118, 3391-3400. [Google Scholar] [CrossRef] [PubMed]
[35] Liu, N., Jiang, F., Han, X.-Y., Li, M., Chen, W.-J., Liu, Q.-C., Liao, C.-X. and Lv, Y.-F. (2018) MiRNA-155 Promotes the Invasion of Colorectal Cancer SW-480 Cells through Regulating the Wnt/β-Catenin. European Review for Medical and Pharmacological Sciences, 22, 101-109.
[36] 吕桂帅, 陈磊, 王红阳. 我国肝癌研究的现状与前景[J]. 生命科学, 2015, 27(3): 237-248.
[37] Wang, Q., Wang, G.-T. and Lu, W.-H. (2021) MiR-155 Inhibits Malignant Biological Behavior of Human Liver Cancer Cells by Regulating SRPK1. Technolo-gy in Cancer Research & Treatment, 20, Article ID: 1533033820957021. [Google Scholar] [CrossRef] [PubMed]
[38] Niu, L.-J., Huang, T., Wang, L., Sun, X.-F. and Zhang, Y.-M. (2022) HBX Suppresses PTEN to Promote the Malignant Progression of Hepatocellular Carcinoma through mi-R155 Activation. Annals of Hepatology, 27, Article ID: 100688. [Google Scholar] [CrossRef] [PubMed]
[39] Zheng, Z., Sun, R., Zhao, H.-J., Fu, D., Zhong, H.-J., Weng, X.-Q., Qu, B., Zhao, Y., Wang, L. and Zhao, W.-L. (2019) MiR155 Sensitized B-Lymphoma Cells to Anti-PD-L1 Antibody via PD-1/PD-L1-Mediated Lymphoma Cell Interaction with CD8+T Cells. Molecular Cancer, 18, Article No. 54. [Google Scholar] [CrossRef] [PubMed]
[40] Ahmadvand, M., Eskandari, M., Pashaiefar, H., Yaghmaie, M., Manoochehrabadi, S., Khakpour, G., Sheikhsaran, F. and Montazer Zohour, M. (2018) Over Expression of Circulating miR-155 Predicts Prognosis in Diffuse Large B-Cell Lymphoma. Leukemia Research, 70, 45-48. [Google Scholar] [CrossRef] [PubMed]
[41] Yu, Y., Kou, D., Liu, B., Huang, Y., Li, S., Qi, Y., Guo, Y., Huang, T., Qi, X. and Jia, L. (2020) LncRNA MEG3 Contributes to Drug Resistance in Acute Myeloid Leukemia by Positively Regulating ALG9 through Sponging miR-155. International Journal of Laboratory Hematology, 42, 464-472. [Google Scholar] [CrossRef] [PubMed]
[42] Wang, H. and Men, C.-P. (2015) Correlation of Increased Expression of MicroRNA-155 in Bladder Cancer and Prognosis. Laboratory Medicine, 46, 118-122. [Google Scholar] [CrossRef] 
[43] Yang, L., Li, C., Liang, F., Fan, Y. and Zhang, S. (2017) MiRNA-155 Promotes Proliferation by Targeting Caudal-Type Homeobox 1 (CDX1) in Glioma Cells. Biomedicine & Pharmacotherapy, 95, 1759-1764. [Google Scholar] [CrossRef] [PubMed]
[44] Chen, W., He, L.-N., Liang, Y., Zeng, X., Wu, C.-P., Su, M.-Q., Cheng, Y. and Liu, J.-H. (2020) TERF1 Downregulation Promotes the Migration and Invasion of the PC3 Prostate Can-cer Cell Line as a Target of miR-155. Molecular Medicine Reports, 22, 5209-5218. [Google Scholar] [CrossRef] [PubMed]

为你推荐